In February, the US Food and Drug Administration approved irinotecan liposome (Onivyde) as part of a new regimen for first-line metastatic pancreatic adenocarcinoma called NALIRIFOX. The […]

For breast cancer survivors harboring BRCA1/2 gene mutations, the prospect of future pregnancy often raises concerns because of limited data on the safety of assisted reproductive […]

The numbers of cancer cases and deaths are rising in Canada, even as overall rates of cancer incidence and mortality continue to decline, new research suggested. […]

LONDON (Reuters) -An infected blood scandal in Britain was no accident but the fault of doctors and a succession of governments that led to 3,000 deaths […]

BRCA is no longer the only gene that identifies hereditary breast cancer (BC) syndromes. Pathogenic variants of CDH1 identify a form of hereditary lobular BC (HLBC) […]

A relatively high percentage of men in their 70s and 80s, as well those determined to have a limited life expectancy, report receiving prostate cancer screening, […]

A major trial has demonstrated that low risk prostate cancers do not fare better by adding 6 months of hormone treatment to radiotherapy following radical prostatectomy, […]